Live Breaking News & Updates on About Generalised Anxiety

Stay updated with breaking news from About generalised anxiety. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Incannex Announces Positive Topline Results from Phase 2

Highlights: PsiGAD1 trial achieves primary endpoint; PsiGAD psilocybin-assisted therapy demonstrated a statistically significant HAM-A reduction of 12.8. ....

South Australia , United States , Joel Latham , Paul Liknaitzky , Laine Yonker , Edison Group , Clinical Psychedelic Lab At Monash University , Incannex Healthcare Inc , Drug Administration , Investigational New Drug , Clinical Psychedelic Lab , Monash University , About Generalised Anxiety , Anxiety Disorder , Incannex Board , Securities Litigation Reform Act , Executive Officer , Relations Contact , Existing Registered Treatments ,

Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder

Highlights:PsiGAD1 trial achieves primary endpoint; PsiGAD psilocybin-assisted therapy demonstrated a statistically significant HAM-A reduction of. ....

South Australia , United States , Laine Yonker , Joel Latham , Paul Liknaitzky , Incannex Healthcare Inc , Edison Group , Drug Administration , Clinical Psychedelic Lab At Monash University , Investigational New Drug , Clinical Psychedelic Lab , Monash University , About Generalised Anxiety , Anxiety Disorder , Incannex Board , Securities Litigation Reform Act , Executive Officer , Relations Contact , Existing Registered Treatments ,